American Association of Neuromuscular & Electrodiagnostic Medicine (AANEM)

In this comprehensive discussion, four prominent neuromuscular experts—Drs. Bhaskar Roy, Jeff Allen, Diana Castro, and Luis Querol—explore recent developments in Chronic Inflammatory Demyelinating Polyneuropathy (CIDP). The conversation centers on the new European Academy of Neurology and Peripheral Nerve Society guidelines, highlighting significant changes in diagnostic criteria and disease classification. The experts discuss the challenges of diagnosing CIDP, particularly in pediatric cases and variant forms, while emphasizing the importance of proper electrodiagnostic testing and the role of supportive criteria like CSF studies and MRI. They delve into the emerging field of autoimmune neuropathies and the significance of specific antibody testing. The podcast concludes with a discussion of treatment options, including traditional approaches (IVIG, corticosteroids, plasmapheresis) and newer therapies such as FcRn inhibitors and complement-targeting drugs, while also addressing the controversial role of rituximab in CIDP treatment. Throughout the discussion, the experts stress the importance of regular diagnostic reassessment and the need for more personalized treatment approaches based on patient profiles.

This podcast discusses paraproteinemic neuropathies,

Despite its recognition for nearly 40 years, anti-MAG neuropathy continues to have limited therapeutic options. The emergence of bruton tyrosine kinase inhibition as a new therapeutic pathway appears promising. In this interview, Dr. Amro Stino interviews Dr. Chiara Briani on her 2023 paper exploring the prevalence of the MYD 88 mutation among patients with anti-MAG neuropathy. This is discussed within the broader context of disease presentation, current treatment landscape, and future drug development.

Dr. Andrés De León interviews Drs. Simon Podnar and Gregor Omejec about their research on recovery of ulnar nerve conduction block at the elbow. 

Dr. Chilvana Patel interviews Dr. Khadilkar on the article

Carrie Ford, CNCT, RNSCT, REPT (Emeritus) interviews Peter Grant, MD who is a fraud and abuse expert for the FBI Office of Inspector General, US Attorney’s Office, private insurers, and state medical boards. During this podcast, Peter discusses AANEM lab accreditation—how and when it got started. Dr. Grant explains how to apply for lab accreditation, the benefits of being an accredited lab, exemplary accreditation status vs regular accreditation, and how the HB2639 will affect lab accreditation.

Carrie Ford, CNCT, RNSCT, REPT (Emeritus) interviews Peter Grant, MD who is a fraud and abuse expert for the FBI, Office of Inspector General, US Attorney’s Office, private insurers, and state medical boards. In this podcast Dr. Grant discusses promoting quality electrodiagnostic medicine through legislation—HB2639 explaining the history and need for this legislation, as well as explaining EDX “fraudsters,” and roadblocks that have occurred with this legislation. Dr. Grant also discusses the AANEM’s state liaisons, lobbying in Washington, DC, and meetings with congressman Pete Sessions for support of HB2639.

Join this Lessons From the Lab as Dr. Devon Rubin picks the amazing brains of Drs. Donald Sanders and Janice Massey on the approach to a patient with weakness. Learn what it means when a patient walks into the office sucking on hard candy as well as what tools should be used to think about and assess for an uncommon neuromuscular disorder.

Carrie Ford, CNCT, RNSCT, REPT (Emeritus), interviews Peter Grant, MD, for a podcast on electrodiagnostic (EDX) fraud and abuse. Dr. Grant is a fraud and abuse expert for the FBI, Office of Inspector General, US Attorney’s Office, private insurers, and state medical boards. In this podcast, Dr. Grant explains EDX fraud and how it adversely affects PM&R and neurology, which includes hand-held devices, billing unnecessary repeat studies, billing unnecessary multiple nerves with EMG, and mobile diagnostic labs.